Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cholesterol Biosynthesis Pathway WP197,4.391827033623989e-09,68.21596244131456,1312.7152727348318,"['IDI1', 'SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'FDFT1']",6.104639576737344e-07,0,0,6
2,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,3.6790060082179514e-06,17.022300469483568,212.99779795827416,"['IDI1', 'SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'FDFT1']",0.00025569091757114763,0,0,6
3,Statin inhibition of cholesterol production WP430,3.4110896651703614e-05,26.896296296296295,276.652443950069,"['SQLE', 'HMGCR', 'LDLR', 'FDFT1']",0.0015804715448622675,0,0,4
4,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,4.7888112737744785e-05,10.370016710432084,103.14685674279656,"['IDI1', 'SQLE', 'HMGCS1', 'HMGCR', 'LDLR', 'FDFT1']",0.0016641119176366312,0,0,6
5,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.00011423964359825842,42.95172413793104,389.88191345993255,"['IDI1', 'HMGCS1', 'HMGCR']",0.003175862092031584,0,0,3
6,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.0005099658126858239,23.118302387267903,175.26370811298233,"['HMGCS1', 'HMGCR', 'LDLR']",0.011814207993888255,0,0,3
7,Mevalonate pathway WP3963,0.0020489701999956743,39.81917808219178,246.49735489413493,"['HMGCS1', 'HMGCR']",0.040686693971342676,0,0,2
8,Glycolysis in senescence WP5049,0.005226223214247802,22.115677321156774,116.19723713827985,"['PKM', 'ALDOC']",0.09080562834755557,0,0,2
9,Vitamin B12 metabolism WP1533,0.024079052894525034,9.03922789539228,33.683896257436594,"['CUBN', 'LDLR']",0.34782944158813356,0,0,2
10,Genes controlling nephrogenesis WP4823,0.027986047496259107,8.284817351598173,29.62691443504285,"['CXCL12', 'PDGFB']",0.34782944158813356,0,0,2
11,Neovascularisation processes WP4331,0.030028441000414408,7.952876712328767,27.879686621334876,"['CXCL12', 'PDGFB']",0.34782944158813356,0,0,2
12,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.030028441000414408,7.952876712328767,27.879686621334876,"['YAP1', 'FERMT3']",0.34782944158813356,0,0,2
13,Glycolysis and Gluconeogenesis WP534,0.03428417377034729,7.3627600202942665,24.835115524908222,"['PKM', 'ALDOC']",0.3563736694728972,0,0,2
14,Pathways in clear cell renal cell carcinoma WP4018,0.03867987687727244,4.2160271976687715,13.712357755689984,"['PKM', 'PDGFB', 'ALDOC']",0.3563736694728972,0,0,3
15,Composition of Lipid Particles WP3601,0.03970635197353262,32.961451247165535,106.34168777031095,['LDLR'],0.3563736694728972,0,0,1
16,Target Of Rapamycin (TOR) Signaling WP1471,0.045859239020783024,6.210188356164384,19.14090962364535,"['IDI1', 'HMGCR']",0.3563736694728972,0,0,2
17,EV release from cardiac cells and their functional effects WP3297,0.04938578351509048,24.71938775510204,74.3582093429276,['CXCL12'],0.3563736694728972,0,0,1
18,Vitamin D Receptor Pathway WP2877,0.05762645417306293,3.560344827586207,10.160417872482148,"['IGFBP5', 'SOSTDC1', 'ZNF257']",0.3563736694728972,0,0,3
19,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.05762645417306293,3.560344827586207,10.160417872482148,"['UCP3', 'NDUFA2', 'COX7A1']",0.3563736694728972,0,0,3
20,"GPCRs, Class A Rhodopsin-like WP455",0.05762645417306293,3.560344827586207,10.160417872482148,"['NPFFR1', 'OPRK1', 'OR6A2']",0.3563736694728972,0,0,3
21,Cellular Proteostasis WP4918,0.05896830502069522,19.774149659863944,55.975776628413975,['PFDN6'],0.3563736694728972,0,0,1
22,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.05896830502069522,19.774149659863944,55.975776628413975,['VEGFB'],0.3563736694728972,0,0,1
23,Osteoblast Signaling WP322,0.05896830502069522,19.774149659863944,55.975776628413975,['PDGFB'],0.3563736694728972,0,0,1
24,Serotonin Transporter Activity WP1455,0.06845487943293131,16.47732426303855,44.18527053229482,['IL1R1'],0.3626962583555876,0,0,1
25,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.069649068290999,4.843969261610424,12.905719274323522,"['PPP1CC', 'PPP1R14B']",0.3626962583555876,0,0,2
26,Prader-Willi and Angelman Syndrome WP3998,0.07538433336313814,4.6180312201338,11.938330220497628,"['GABRR2', 'SNURF']",0.3626962583555876,0,0,2
27,Bile acids synthesis and enterohepatic circulation  WP4389,0.07784646048088459,14.122448979591837,36.054850174556435,['LDLR'],0.3626962583555876,0,0,1
28,Exercise-induced Circadian Regulation WP410,0.07830672332551195,4.512764632627646,11.494561234711096,"['IDI1', 'UCP3']",0.3626962583555876,0,0,2
29,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.08714399262540906,12.356292517006803,30.151743952943942,['LDLR'],0.3626962583555876,0,0,1
30,Vitamin B12 Disorders WP4271,0.08714399262540906,12.356292517006803,30.151743952943942,['CUBN'],0.3626962583555876,0,0,1
31,Cytosine methylation WP3585,0.08714399262540906,12.356292517006803,30.151743952943942,['TDG'],0.3626962583555876,0,0,1
32,EDA signaling in hair follicle development WP3930,0.08714399262540906,12.356292517006803,30.151743952943942,['SOSTDC1'],0.3626962583555876,0,0,1
33,Osteoclast Signaling WP12,0.08714399262540906,12.356292517006803,30.151743952943942,['PDGFB'],0.3626962583555876,0,0,1
34,Mitochondrial complex I assembly model OXPHOS system WP4324,0.09033795148915051,4.135559360730594,9.94270199138294,"['NDUFAF4', 'NDUFA2']",0.3626962583555876,0,0,2
35,DNA IR-double strand breaks and cellular response via ATM WP3959,0.09342632749596674,4.050880626223092,9.602945079464991,"['YAP1', 'BRCA1']",0.3626962583555876,0,0,2
36,miR-509-3p alteration of YAP1/ECM axis WP3967,0.0963484110912569,10.982615268329553,25.696951604406383,['YAP1'],0.3626962583555876,0,0,1
37,Selenium Micronutrient Network WP15,0.096545047188178,3.9695890410958903,9.279889192839233,"['PRDX5', 'LDLR']",0.3626962583555876,0,0,2
38,Computational Model of Aerobic Glycolysis WP4629,0.10546064193821164,9.883673469387755,22.232507649908342,['PKM'],0.38576392708977414,0,0,1
39,IL1 and megakaryocytes in obesity WP2865,0.11448160211271903,8.984539270253556,19.472561666453863,['IL1R1'],0.39782356734169866,0,0,1
40,Galanin receptor pathway WP4970,0.11448160211271903,8.984539270253556,19.472561666453863,['YAP1'],0.39782356734169866,0,0,1
41,Matrix Metalloproteinases WP129,0.12341219956705111,8.235260770975056,17.230021023006774,['MMP21'],0.418397457068783,0,0,1
42,Hypertrophy Model WP516,0.1322533332597202,7.601255886970173,15.37761433745889,['IL1R1'],0.4376955553119311,0,0,1
43,Mitochondrial complex III assembly WP4921,0.14100589331393232,7.057823129251701,13.825947977274732,['CYC1'],0.4464537814801111,0,0,1
44,Nonalcoholic fatty liver disease WP4396,0.14132349917356035,2.3666666666666667,4.630865414241381,"['NDUFA2', 'CYC1', 'COX7A1']",0.4464537814801111,0,0,3
45,MECP2 and Associated Rett Syndrome WP3584,0.146379726672517,3.0503688092729186,5.861439742361949,"['GABRR2', 'OPRK1']",0.4489098871643443,0,0,2
46,Apoptosis Modulation and Signaling WP1772,0.14986933137843697,3.0039435450394354,5.701459280956376,"['ENDOG', 'IL1R1']",0.4489098871643443,0,0,2
47,Imatinib and Chronic Myeloid Leukemia WP3640,0.15824880914426528,6.174744897959184,11.383677836154384,['SPRED2'],0.4489098871643443,0,0,1
48,Nanomaterial induced apoptosis WP2507,0.15824880914426528,6.174744897959184,11.383677836154384,['ENDOG'],0.4489098871643443,0,0,1
49,"GPCRs, Class B Secretin-like WP334",0.15824880914426528,6.174744897959184,11.383677836154384,['CALCR'],0.4489098871643443,0,0,1
50,Monoamine Transport WP727,0.18347063282389664,5.198711063372717,8.81545779899626,['IL1R1'],0.493475631061816,0,0,1
51,Angiogenesis WP1539,0.19170995739092134,4.93843537414966,8.157167732597014,['PDGFB'],0.493475631061816,0,0,1
52,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.19170995739092134,4.93843537414966,8.157167732597014,['PDGFB'],0.493475631061816,0,0,1
53,Heart Development WP1591,0.19170995739092134,4.93843537414966,8.157167732597014,['VEGFB'],0.493475631061816,0,0,1
54,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.19170995739092134,4.93843537414966,8.157167732597014,['LTBP1'],0.493475631061816,0,0,1
55,7-oxo-C and 7beta-HC pathways WP5064,0.19986669782510658,4.702947845804989,7.57223817419563,['ACOT11'],0.5051176545034511,0,0,1
56,Fluoropyrimidine Activity WP1601,0.2079416762812035,4.48886827458256,7.049757036418826,['TDG'],0.5161409464837016,0,0,1
57,Signal transduction through IL1R WP4496,0.22384959542505012,4.11422902494331,6.158099429529677,['IL1R1'],0.5219082405150544,0,0,1
58,Gastric Cancer Network 2 WP2363,0.22384959542505012,4.11422902494331,6.158099429529677,['SNURF'],0.5219082405150544,0,0,1
59,Focal Adhesion WP306,0.2266723384674843,1.859353448275862,2.759744885451964,"['PPP1CC', 'VEGFB', 'PDGFB']",0.5219082405150544,0,0,3
60,Oxysterols derived from cholesterol WP4545,0.2316841400870531,3.9493877551020407,5.77550685049197,['ACOT11'],0.5219082405150544,0,0,1
61,TYROBP causal network in microglia WP3945,0.2471183503689293,3.6563366087175613,5.111148724930532,['LOXL3'],0.5219082405150544,0,0,1
62,Peptide GPCRs WP24,0.2471183503689293,3.6563366087175613,5.111148724930532,['OPRK1'],0.5219082405150544,0,0,1
63,NRF2 pathway WP2884,0.2483926711828077,2.127853881278539,2.9635566483521414,"['SLC2A12', 'PDGFB']",0.5219082405150544,0,0,2
64,Differentiation Pathway WP2848,0.25471957285332447,3.5255102040816326,4.821459738767428,['PDGFB'],0.5219082405150544,0,0,1
65,Base Excision Repair WP4752,0.2622445653128542,3.403706310110251,4.555785181408422,['TDG'],0.5219082405150544,0,0,1
66,Lung fibrosis WP3624,0.2622445653128542,3.403706310110251,4.555785181408422,['PDGFB'],0.5219082405150544,0,0,1
67,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.26969408717952376,3.2900226757369615,4.311466056222733,['PKM'],0.5219082405150544,0,0,1
68,Type 2 papillary renal cell carcinoma WP4241,0.28436971864887517,3.083971088435374,3.8780321531282276,['PDGFB'],0.5219082405150544,0,0,1
69,ATM Signaling Pathway WP2516,0.29159730972719106,2.9903112760255617,3.6852043101432472,['BRCA1'],0.5219082405150544,0,0,1
70,Vitamin D-sensitive calcium signaling in depression WP4698,0.29159730972719106,2.9903112760255617,3.6852043101432472,['CALB1'],0.5219082405150544,0,0,1
71,DNA Replication WP466,0.29159730972719106,2.9903112760255617,3.6852043101432472,['GMNN'],0.5219082405150544,0,0,1
72,Mesodermal commitment pathway WP2857,0.293225625828785,1.8831050228310502,2.3102175571910744,"['YAP1', 'SLC2A12']",0.5219082405150544,0,0,2
73,Netrin-UNC5B signaling pathway WP4747,0.29875239305048745,2.9021608643457384,3.5062171071256265,['YAP1'],0.5219082405150544,0,0,1
74,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.29875239305048745,2.9021608643457384,3.5062171071256265,['IGFBP5'],0.5219082405150544,0,0,1
75,Fas ligand pathway and stress induction of heat shock proteins WP314,0.29875239305048745,2.9021608643457384,3.5062171071256265,['MAPKAPK3'],0.5219082405150544,0,0,1
76,Folate Metabolism WP176,0.305835691177183,2.8190476190476192,3.33974623182191,['LDLR'],0.5219082405150544,0,0,1
77,Hepatitis C and Hepatocellular Carcinoma WP3646,0.305835691177183,2.8190476190476192,3.33974623182191,['BRCA1'],0.5219082405150544,0,0,1
78,Nephrotic syndrome WP4758,0.3128479193967948,2.740551776266062,3.1846255435306636,['CUBN'],0.5219082405150544,0,0,1
79,Proximal tubule transport WP4917,0.3128479193967948,2.740551776266062,3.1846255435306636,['SLC13A3'],0.5219082405150544,0,0,1
80,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.3128479193967948,2.740551776266062,3.1846255435306636,['CXCL12'],0.5219082405150544,0,0,1
81,TGF-beta Signaling Pathway WP366,0.31925166917077813,1.764554794520548,2.014725531024536,"['YAP1', 'ETS1']",0.5219082405150544,0,0,2
82,Allograft Rejection WP2328,0.3197897859985302,2.666298952013238,3.039824552502425,['CXCL12'],0.5219082405150544,0,0,1
83,Integrated Cancer Pathway WP1971,0.3197897859985302,2.666298952013238,3.039824552502425,['BRCA1'],0.5219082405150544,0,0,1
84,PDGF Pathway WP2526,0.3197897859985302,2.666298952013238,3.039824552502425,['PDGFB'],0.5219082405150544,0,0,1
85,DNA Repair Pathways Full Network WP4946,0.3266501730342317,1.7333573660177841,1.9393937351591122,"['TDG', 'BRCA1']",0.5219082405150544,0,0,2
86,Metabolic reprogramming in colon cancer WP4290,0.3266619922648182,2.595954171142141,2.9044296023605654,['PKM'],0.5219082405150544,0,0,1
87,Common Pathways Underlying Drug Addiction WP2636,0.3266619922648182,2.595954171142141,2.9044296023605654,['PPP1CC'],0.5219082405150544,0,0,1
88,TGF-beta Receptor Signaling WP560,0.33346523249955506,2.5292168149311007,2.7776280667778264,['LTBP1'],0.5267234922436154,0,0,1
89,MAPK Signaling Pathway WP382,0.34958052372701637,1.4466610597140455,1.5204716555110371,"['MAPKAPK3', 'IL1R1', 'PDGFB']",0.5419089000026074,0,0,3
90,Myometrial relaxation and contraction pathways WP289,0.35965532315441595,1.6055240004454838,1.6418235203126745,"['IGFBP5', 'IGFBP6']",0.5419089000026074,0,0,2
91,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.36000218027703473,2.2933080208827716,2.34294711153312,['LTBP1'],0.5419089000026074,0,0,1
92,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.36647076690823804,2.2410327767470624,2.2496305521218805,['IL1R1'],0.5419089000026074,0,0,1
93,Energy Metabolism WP1541,0.36647076690823804,2.2410327767470624,2.2496305521218805,['UCP3'],0.5419089000026074,0,0,1
94,RANKL/RANK signaling pathway WP2018,0.36647076690823804,2.2410327767470624,2.2496305521218805,['CALCR'],0.5419089000026074,0,0,1
95,Endochondral Ossification with Skeletal Dysplasias WP4808,0.3792137613819162,2.143300798580302,2.0782628045779052,['HMGCS1'],0.5434094106400655,0,0,1
96,Endochondral Ossification WP474,0.3792137613819162,2.143300798580302,2.0782628045779052,['HMGCS1'],0.5434094106400655,0,0,1
97,Genotoxicity pathway WP4286,0.3792137613819162,2.143300798580302,2.0782628045779052,['PHLDA3'],0.5434094106400655,0,0,1
98,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.38548945803011936,2.0975539151830946,1.9994752990188078,['ETS1'],0.5451241878435688,0,0,1
99,Integrated breast cancer pathway WP1984,0.3920609856150779,1.4951224574512245,1.399939785786471,"['HMGCR', 'BRCA1']",0.5451241878435688,0,0,2
100,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.3978524243794938,2.011661807580175,1.8540966573690807,['ETS1'],0.5451241878435688,0,0,1
101,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.3978524243794938,2.011661807580175,1.8540966573690807,['CXCL12'],0.5451241878435688,0,0,1
102,IL-1 signaling pathway WP195,0.40394094494883154,1.9712925170068027,1.7869502268535298,['IL1R1'],0.5451241878435688,0,0,1
103,Oxidative phosphorylation WP623,0.40394094494883154,1.9712925170068027,1.7869502268535298,['NDUFA2'],0.5451241878435688,0,0,1
104,DNA damage response WP707,0.4218420320241889,1.8593248620202798,1.6048285940616471,['BRCA1'],0.5579027381436185,0,0,1
105,PI3K-Akt signaling pathway WP4172,0.42585875068080503,1.2703270682255439,1.0844116007527234,"['VEGFB', 'PDGFB', 'BRCA1']",0.5579027381436185,0,0,3
106,Oncostatin M Signaling Pathway WP2374,0.4276895828984842,1.8247669438145628,1.5498797087087528,['LDLR'],0.5579027381436185,0,0,1
107,MET in type 1 papillary renal cell carcinoma WP4205,0.4334783864713007,1.7914656771799629,1.4975100616520183,['ETS1'],0.5579027381436185,0,0,1
108,miRNA regulation of DNA damage response WP1530,0.4334783864713007,1.7914656771799629,1.4975100616520183,['BRCA1'],0.5579027381436185,0,0,1
109,Acute viral myocarditis WP4298,0.4392090289959082,1.7593537414965987,1.44756077440571,['ENDOG'],0.5591003785220098,0,0,1
110,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.4448820908403708,1.7283685403986155,1.399885179476558,['YAP1'],0.5591003785220098,0,0,1
111,AMP-activated protein kinase (AMPK) signaling WP1403,0.45049814672277044,1.6984517945109079,1.3543476957066531,['HMGCR'],0.5591003785220098,0,0,1
112,Pathways affected in adenoid cystic carcinoma WP3651,0.45049814672277044,1.6984517945109079,1.3543476957066531,['BRCA1'],0.5591003785220098,0,0,1
113,Melanoma WP4685,0.4724036054145302,1.58843537414966,1.1912019378171808,['ETS1'],0.5760008873036816,0,0,1
114,Neural Crest Differentiation WP2064,0.4724036054145302,1.58843537414966,1.1912019378171808,['ETS1'],0.5760008873036816,0,0,1
115,Amino Acid metabolism WP3925,0.5036458007222971,1.4476790716286514,0.9929370666889369,['PKM'],0.6087544895686895,0,0,1
116,DNA IR-damage and cellular response via ATR WP4016,0.5234458954842712,1.3668745275888132,0.8848074137474831,['BRCA1'],0.6272325816578768,0,0,1
117,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5282720779282172,1.3480570310315907,0.860254275345119,['MAPKAPK3'],0.6276052891625828,0,0,1
118,Glioblastoma signaling pathways WP2261,0.5424612655983592,1.2945757250268528,0.7918124787873518,['BRCA1'],0.6335417256042452,0,0,1
119,Spinal Cord Injury WP2431,0.5516843820132721,1.2612070469213326,0.7501396779728671,['IL1R1'],0.6335417256042452,0,0,1
120,B Cell Receptor Signaling Pathway WP23,0.5516843820132721,1.2612070469213326,0.7501396779728671,['ETS1'],0.6335417256042452,0,0,1
121,Wnt signaling pathway and pluripotency WP399,0.5562264501088562,1.245156290364247,0.7303835069526762,['LDLR'],0.6335417256042452,0,0,1
122,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5562264501088562,1.245156290364247,0.7303835069526762,['PDGFB'],0.6335417256042452,0,0,1
123,Senescence and Autophagy in Cancer WP615,0.5607228082724014,1.2295068027210885,0.7113048473872536,['IGFBP5'],0.6335417256042452,0,0,1
124,Androgen receptor signaling pathway WP138,0.5651739134886792,1.21424372218023,0.6928739186158841,['BRCA1'],0.6335417256042452,0,0,1
125,DNA damage response (only ATM dependent) WP710,0.5951020048188985,1.1171150278293136,0.5798077803064149,['LDLR'],0.6565014180144992,0,0,1
126,Hippo-Merlin Signaling Dysregulation WP4541,0.5951020048188985,1.1171150278293136,0.5798077803064149,['PPP1CC'],0.6565014180144992,0,0,1
127,ESC Pluripotency Pathways WP3931,0.6032706549987856,1.0921390778533635,0.5519554428619168,['PDGFB'],0.658967485894118,0,0,1
128,Ciliary landscape WP4352,0.6068189798161663,0.9821232876712329,0.49059489314135984,"['YAP1', 'EXOSC4']",0.658967485894118,0,0,2
129,Nuclear Receptors Meta-Pathway WP2882,0.622790304875814,0.9531187657933236,0.4513450130453287,"['SLC2A12', 'PDGFB']",0.6710686230832413,0,0,2
130,Cell cycle WP179,0.630592953907833,1.012833999579213,0.4670123948225319,['CDC14A'],0.6742493891783753,0,0,1
131,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.6700763894334573,0.8714764079147641,0.3489073962716261,"['VEGFB', 'PDGFB']",0.7035195037573648,0,0,2
132,Chemokine signaling pathway WP3929,0.6731517553937375,0.9005804156524996,0.3564357549563103,['CXCL12'],0.7035195037573648,0,0,1
133,Endoderm differentiation WP2853,0.6731517553937375,0.9005804156524996,0.3564357549563103,['SLC2A12'],0.7035195037573648,0,0,1
134,Breast cancer pathway WP4262,0.6956898555253885,0.8458245367112363,0.3069085562641565,['BRCA1'],0.721648432224097,0,0,1
135,Regulation of Actin Cytoskeleton WP51,0.7195628469609431,0.7908163265306123,0.26026667498266637,['PDGFB'],0.7408832276116377,0,0,1
136,VEGFA-VEGFR2 Signaling Pathway WP3888,0.737816559688949,0.7814620689655173,0.2376113952829077,"['SH3BGRL3', 'ETS1', 'SLC25A25']",0.7540919249762051,0,0,3
137,Ras signaling WP4223,0.7783238872383121,0.6660187884677681,0.16691265622383805,['ETS1'],0.7896862797527401,0,0,1
138,Circadian rhythm related genes WP3594,0.7872140606010274,0.6481957021219084,0.15508410929554434,['PPP1CC'],0.7929185103155276,0,0,1
139,Ciliopathies WP4803,0.7998895524676921,0.6231639152476277,0.139141048684475,['AK7'],0.7998895524676921,0,0,1
